Federated Hermes’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-164,424
Closed -$3.85M 2270
2022
Q3
$3.85M Sell
164,424
-349,794
-68% -$11.2M 0.01% 729
2022
Q2
$14.9M Sell
514,218
-534,982
-51% -$23.4M 0.04% 456
2022
Q1
$57.8M Sell
1,049,200
-193
-0% -$9.55K 0.13% 203
2021
Q4
$56M Buy
1,049,393
+79,986
+8% +$3.71M 0.1% 250
2021
Q3
$41M Buy
969,407
+35,979
+4% +$1.84M 0.08% 324
2021
Q2
$62.2M Buy
933,428
+108,451
+13% +$5.89M 0.12% 234
2021
Q1
$36.5M Buy
824,977
+684,667
+488% +$25.4M 0.07% 350
2020
Q4
$4.07M Buy
140,310
+83,648
+148% +$2.08M 0.01% 865
2020
Q3
$1.24M Buy
+56,662
New +$1.01M ﹤0.01% 1167
2020
Q2
Sell
-154,744
Closed -$1.01M 2361
2020
Q1
$1.01M Buy
154,744
+62,403
+68% +$889K ﹤0.01% 1138
2019
Q4
$1.45M Buy
+92,341
New +$1.05M ﹤0.01% 1130

Other funds holding SGRY

Federated Hermes's SGRY Position: Q4 2022 in Review

Federated Hermes sold out of Surgery Partners (SGRY) in Q4 2022, closing a stake of 164,424 shares — an estimated $3.85M sold.

Federated Hermes first reported a position in SGRY in Q4 2019 and held it in 11 quarters. The position peaked at $62.2M in Q2 2021. 161 funds tracked by Wall St. Rank hold SGRY as of Q4 2022.

  • Federated Hermes reported no remaining Surgery Partners position as of Q4 2022 after selling out during the quarter.
  • Federated Hermes sold 164,424 Surgery Partners shares in Q4 2022, an estimated $3.85M.
  • Federated Hermes first reported a position in Surgery Partners in Q4 2019 and held it in 11 quarters.
  • Federated Hermes's Surgery Partners position peaked at $62.2M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2022.

Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.